1. Advances in research of extracellular mechanisms underlying gemcitabine resistance in pancreatic cancer
    Zong-Ting Gu et al, 2021, World Chinese Journal of Digestology CrossRef
  2. The P2X7 Receptor Stimulates IL-6 Release from Pancreatic Stellate Cells and Tocilizumab Prevents Activation of STAT3 in Pancreatic Cancer Cells
    Lara Magni et al, 2021, Cells CrossRef
  3. Protonation of Piezo1 Impairs Cell-Matrix Interactions of Pancreatic Stellate Cells
    Anna Kuntze et al, 2020, Frontiers in Physiology CrossRef
  4. From Genetic Alterations to Tumor Microenvironment: The Ariadne’s String in Pancreatic Cancer
    Chiara Bazzichetto et al, 2020, Cells CrossRef
  5. Stellate Cells Aid Growth-Permissive Metabolic Reprogramming and Promote Gemcitabine Chemoresistance in Pancreatic Cancer
    Manoj Amrutkar et al, 2021, Cancers CrossRef
  6. Role of Pancreatic Stellate Cell-Derived Exosomes in Pancreatic Cancer-Related Diabetes: A Novel Hypothesis
    Chamini J. Perera et al, 2021, Cancers CrossRef
  7. The Metabolism Symbiosis Between Pancreatic Cancer and Tumor Microenvironment
    Ying Li et al, 2021, Frontiers in Oncology CrossRef
  8. Stellate Cells in the Tumor Microenvironment
    David Roife et al, 2020, Tumor Microenvironment CrossRef
  9. TGF-β1 Receptor Inhibitor SB525334 Attenuates the Epithelial to Mesenchymal Transition of Peritoneal Mesothelial Cells via the TGF-β1 Signaling Pathway
    Jung-Yoon Heo et al, 2021, Biomedicines CrossRef